Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
2.960
+0.240 (8.82%)
At close: May 12, 2025, 4:00 PM
2.860
-0.100 (-3.38%)
After-hours: May 12, 2025, 7:29 PM EDT

Atea Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-139.49-168.39-135.96-115.91121.19-10.95
Upgrade
Depreciation & Amortization
0.420.420.420.260.030.02
Upgrade
Loss (Gain) From Sale of Investments
-10.07-11.82-15.45-5.47--
Upgrade
Stock-Based Compensation
46.1351.7749.4346.7239.627.46
Upgrade
Change in Accounts Receivable
------5.82
Upgrade
Change in Accounts Payable
-13.750.211.7-1.9810.29-0.49
Upgrade
Change in Unearned Revenue
-----301.37301.37
Upgrade
Change in Other Net Operating Assets
-9.43-7.6814.46-44.643.235.14
Upgrade
Operating Cash Flow
-126.2-135.5-85.4-120.98-87.01296.73
Upgrade
Capital Expenditures
----1.94-0-0.03
Upgrade
Investment in Securities
84.9156.1140.3-453.47--
Upgrade
Investing Cash Flow
84.9156.1140.3-455.41-0-0.03
Upgrade
Issuance of Common Stock
-0.270.260.371.47317.63
Upgrade
Other Financing Activities
------0.02
Upgrade
Financing Cash Flow
-0.230.270.260.371.47531.75
Upgrade
Net Cash Flow
-41.52-79.13-44.84-576.02-85.54828.46
Upgrade
Free Cash Flow
-126.2-135.5-85.4-122.93-87.01296.71
Upgrade
Free Cash Flow Margin
-----24.76%610.10%
Upgrade
Free Cash Flow Per Share
-1.49-1.61-1.02-1.48-0.9913.74
Upgrade
Levered Free Cash Flow
-31.83-39.55-9.76-69.52-127.65300.81
Upgrade
Unlevered Free Cash Flow
-31.83-39.55-9.76-69.52-127.65300.81
Upgrade
Change in Net Working Capital
20.619.1-15.7245.11253.78-300.25
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q